Loading...
•
Mar 31, 2020
Novocure Q1 2020 Earnings Report
Reported revenue growth and financial strength, clinical pipeline developments and the company’s response to COVID-19.
Key Takeaways
Novocure reported a strong quarter with $102 million in net revenues, $4 million in net income, and $331 million cash on hand. Net revenues increased by 39% compared to the first quarter 2019.
Net revenues of $101.8 million, representing 39 percent growth versus the first quarter 2019.
Gross profit of $77.3 million, a 45% increase compared to Q1 2019.
Net income of $4.0 million compared to a net loss of $12.2 million for the same period in 2019.
Cash, cash equivalents and short-term investments at end of period $331.3 million, a 29% increase compared to Q1 2019.
Forward Guidance
Novocure continues to advance its clinical milestones with data readouts expected over the next several years.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...